Clinical Trials in Georgia

Showing 7921-7940 of 14,426 trials

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

NCT04009577

The primary objective of the study is to evaluate the proportion of adult \[greater than or equal to (\>=) 18 years\] participants with insomnia disorder taking zolpidem tartrate immediate release (ZOL-IR) or zolpidem tartrate extended release (ZOL-ER), intermittently or frequently, who transition to lemborexant 5 milligram (mg) (LEM5) or 10 mg (LEM10) after 2 weeks of receiving LEM.

Insomnia

Eisai Inc.53 participantsStarted Jul 2019

Glendale, Arizona, United States • Sacramento, California, United States • San Diego, California, United States +14 more locations

COMPLETEDPhase 363 miles

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

NCT03188185

This study will evaluate the efficacy, safety, and tolerability of adjunctive ALKS 5461 in adults who have treatment refractory MDD.

Major Depressive Disorder

Alkermes, Inc.278 participantsStarted Jun 2017

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Los Alamitos, California, United States +32 more locations

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Find Trials by Condition in Georgia

Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation

Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

A Phase II Study of M2951 in SLE

Essure (Model ESS310) Placement Rate Study

A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist

A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor

ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

Rheos System for the Treatment of HFpEF Heart Failure

UNITE Study: Understanding New Interventions With GBM ThErapy

Study of CAD-1883 for Spinocerebellar Ataxia

Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)

A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer